The Federal Circuit recently held that makers of biosimilars must always notify brand-name rivals six months before commercial product launch. Brian Klock and Kathryn Easterling report.
08/03/2016 | Managing Intellectual Property Blog
1 min
August 21, 2019
August 15, 2019
August 15, 2019
October 15 - 19, 2019 Las Vegas, NV